COPD Exacerbation and Hospital Readmission CME

Reducing the Likelihood of Readmissions Following COPD Exacerbation, presented by Carolyn Rochester, MD, is intended to assist clinicians in incorporating best practices to reduce the likelihood of COPD exacerbation. This presentation covers a range of topics including factors associated with an increased risk of COPD exacerbations and hospital readmissions, risk assessment and reduction, optimization of pharmacotherapy, addressing anxiety and depression, patient self-management, and pulmonary rehabilitation.

Method of Participation

There are no fees for participating in and receiving credit for this activity. Participants must:

  1. Read the learning objectives and faculty disclosures
  2. View the webinar recording and slides
  3. Create a QuestBase account and log in to take the corresponding post-test. Complete the post-test by recording the best answer to each question
  4. Complete the evaluation form (included in the post-test)
  5. Click “submit” to submit your responses

A statement of credit will be issued only upon receipt of a completed post-test with a score of 70% or better. Your certificate will be available upon completion of the post-activity assessment.


After completing this activity, the participant should be better able to:

  1. Describe the patient, provider, and system factors that are associated with increased risk of hospital readmission secondary to COPD exacerbation
  2. Recognize the importance of thorough assessment and patient education (related to symptom triggers, smoking cessation, vaccinations, and medications)
  3. Describe the role anxiety and depression play in symptom exacerbation and hospitalization
  4. List appropriate maintenance medications to reduce risk of symptom exacerbation
  5. List the benefits and components of a pulmonary rehabilitation program


Dr. Carolyn Rochester is a practicing pulmonary disease and critical care specialist in New Haven, Connecticut. She attended and graduated from Columbia University College of Physicians and Surgeons in 1983. Dr. Rochester completed her residency in Internal Medicine at Columbia Presbyterian Medical Center, followed by two years of post-graduate pulmonary fellowship at Columbia Presbyterian Medical Center. She continued her fellowship training in the Section of Pulmonary, Critical Care, and Sleep at the Yale University School of Medicine. She is board certified in Internal Medicine, and has over 35 years of diverse experience.

A widely published author, Dr. Rochester has written for journals including the American Journal of Respiratory and Critical Care Medicine, the Journal of Cardiopulmonary Rehabilitation and Prevention, Clinics in Chest Medicine, and Respiratory Care. Dr. Rochester conducts clinical research in the fields of pulmonary rehabilitation and COPD. She is a member of the Northeast Pulmonary Rehabilitation Consortium.

Dr. Rochester is a longstanding and active member of the American Thoracic Society and the European Respiratory Society. She is actively involved in national and international advocacy to expand access to pulmonary rehabilitation. She lectures nationally and internationally on the topics of COPD and pulmonary rehabilitation.

Dr. Rochester joined the faculty at Yale University School of Medicine in 1991 and is currently Professor of Medicine, and Director of the Yale COPD Program at Yale University School of Medicine and Director of the Pulmonary Rehabilitation Program at the VA Connecticut Healthcare System.

Program Agenda

  1. Factors associated with an increased risk of COPD exacerbations and hospital readmissions
  2. Risk assessment and reduction
  3. Optimization of pharmacotherapy
  4. Addressing anxiety and depression
  5. Patient self-management
  6. Pulmonary rehabilitation

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER) and CHNCT. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Faculty Reported Financial Relationship
Dr. Carolyn Rochester

Co-investigator, GALATHEA study, sponsored by Astra-Zeneca, conducted at Yale University School of Medicine; no direct funds received

Participant, Scientific Advisory Board for COPD, Boehringer Ingelheim and GSK Pharmaceuticals; consulting fees

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Manager Reported Financial Relationship
Community Health Network of Connecticut, Inc. No financial relationships to disclose
Planners at Medical Education Resources No financial relationships to disclose


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources and/or Community Health Network of Connecticut, Inc. (CHNCT). The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources and/or CHNCT. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

This portion of the HUSKY Health website is managed by Community Health Network of Connecticut, Inc., the State of Connecticut’s Medical Administrative Services Organization for the HUSKY Health Program. For the general HUSKY website gateway, please visit HUSKY Health includes Medicaid and the Children’s Health Insurance Program, and is administered by the Connecticut Department of Social Services.